The Benefit of Impella® Support During Protected PCI for Revascularization

January 13, 2017

Drs. John Lasala, Bill O’Neill, Jeff Moses, and Bill Lombardi explain the benefit of Impella support during Protected PCI for revascularization.

Impella 2.5 and Impella CP are now approved by the FDA as safe and effective for use during high-risk PCI procedures. Learn more about the data and the clinical guidelines that support the approval. Additionally, learn how to identify patients who can benefit from Protected PCI and revascularization. Tune into this valuable conversation! Chapters include:

  • Maintaining Hemodynamic stability during high-risk PCI
  • Complete Revascularization is the Therapeutic Goal
  • Clinical Outcomes with PCI


To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: